FDA cleared the Amferia Wound Dressing from Amferia AB on Feb 6, 2026 under DEN250006, a direct 510(k). The device falls under product code SHA, Solid Wound Dressing With Permanently Bound Antimicrobial Agent, regulated at 21 CFR 878.4013 as a Class 2 device. The review panel was General, Plastic Surgery.

FDA logged the submission as received on Mar 3, 2025. The decision came 340 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Amferia AB in the last 12 months of the tracker.